Roselyn J Eisenberg Selected Research

Nectins

2/2008	An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
6/2006	Spatiotemporal changes of the herpes simplex virus entry receptor nectin-1 in murine brain during postnatal development.
9/2005	Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry.
4/2005	Nectin-1/HveC Mediates herpes simplex virus type 1 entry into primary human sensory neurons and fibroblasts.
5/2004	Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.
3/2004	In vivo role of nectin-1 in entry of herpes simplex virus type 1 (HSV-1) and HSV-2 through the vaginal mucosa.
8/2003	Cellular localization of nectin-1 and glycoprotein D during herpes simplex virus infection.
3/2003	Entry of herpes simplex virus type 1 into primary sensory neurons in vitro is mediated by Nectin-1/HveC.
3/2002	Effects of herpes simplex virus on structure and function of nectin-1/HveC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roselyn J Eisenberg Research Topics

Disease

29	Infections 01/2020 - 03/2002
9	Smallpox (Variola) 06/2013 - 03/2004
5	Vaccinia 10/2016 - 02/2006
5	Poxviridae Infections 10/2016 - 11/2005
5	Herpes Genitalis (Genital Herpes) 01/2016 - 03/2004
4	Vesicular Stomatitis 05/2012 - 07/2006
2	Genital Diseases 01/2018 - 03/2011
2	Virus Diseases (Viral Diseases) 11/2014 - 09/2002
1	Asymptomatic Infections 01/2017
1	Neoplasms (Cancer) 01/2017
1	Encephalitis (Encephalitis, Rasmussen) 01/2017
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 06/2006
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2005
1	Melanoma (Melanoma, Malignant) 09/2005
1	Zlotogora-Ogur syndrome 05/2004
1	Mpox (monkeypox) 03/2004
1	Herpes Simplex 08/2003

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2003
12	VaccinesIBA 01/2018 - 03/2004
9	AntibodiesIBA 01/2018 - 03/2003
9	NectinsIBA 02/2008 - 03/2002
8	Glycoproteins (Glycoprotein)IBA 01/2020 - 08/2003
5	Neutralizing AntibodiesIBA 01/2018 - 11/2014
4	EpitopesIBA 01/2018 - 03/2002
4	Membrane Proteins (Integral Membrane Proteins)IBA 10/2016 - 05/2007
4	Subunit VaccinesIBA 07/2014 - 01/2007
3	Monoclonal AntibodiesIBA 01/2018 - 12/2003
3	Immunoglobulins (Immunoglobulin)IBA 10/2016 - 02/2006
2	AntigensIBA 01/2018 - 01/2017
2	Recombinant ProteinsIBA 08/2008 - 10/2005
2	Antiviral Agents (Antivirals)IBA 04/2008 - 05/2007
2	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 01/2007 - 03/2004
1	aluminum sulfate (alum)IBA 01/2017
1	CPG-oligonucleotideIBA 01/2017
1	EmulsionsIBA 01/2017
1	GTP-Binding Proteins (G-Protein)IBA 05/2012
1	Sulfoglycosphingolipids (Sulfatides)IBA 07/2011
1	glycoprotein D-herpes simplex virus type 2IBA 03/2011
1	LigandsIBA 11/2010
1	Immunoglobulin G (IgG)IBA 08/2008
1	GlycosaminoglycansIBA 08/2008
1	Virulence Factors (Pathogenicity Factors)IBA 04/2008
1	SynaptophysinIBA 07/2006
1	OligodeoxyribonucleotidesIBA 06/2006
1	CXC ChemokinesIBA 06/2006
1	vaccinia virus B5 proteinIBA 02/2006
1	Viral Matrix ProteinsIBA 11/2005
1	Ammonium Chloride (Sal Ammoniac)FDA Link 06/2005
1	bafilomycin A1IBA 06/2005
1	Peptides (Polypeptides)IBA 04/2005
1	Green Fluorescent ProteinsIBA 04/2005
1	Biological Warfare AgentsIBA 03/2004
1	afadinIBA 08/2003
1	Heparitin Sulfate (Heparan Sulfate)IBA 09/2002
1	Viral Envelope ProteinsIBA 09/2002

Therapy/Procedure

2	Immunotherapy 09/2007 - 02/2006
1	Mucosal Administration 06/2006
1	Injections 11/2005
1	Therapeutics 11/2005